New estimates for retirement health care costs may be too low

New estimates for retirement health care costs may be too low

Most Americans underestimate their health care costs in retirement, and that’s a problem because those future bills may turn out to be considerably higher than you expect.

A 65-year old man enrolled in Medicare with a Medigap plan will need to stash away $166,000 for medical expenses to have a good chance (90{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) of covering his projected health care costs in retirement, according to new research from the Employee Benefit Research Institute (EBRI), a nonprofit, nonpartisan organization. Due to longer life spans, a 65-year-old woman will need $197,000.

And those may be lowball estimates, experts say, underscoring the need for workers to focus either on ways to reduce those overall costs or use every tool to save up enough.

“Medicare does not cover all health care costs,” Paul Fronstin, director of health benefits research at EBRI, told Yahoo Finance. “As a result, many Medicare beneficiaries purchase Medigap or enroll in Medicare Advantage plans to help offset the out-of-pocket costs of health care. They also enroll in Part D prescription drug plans. The combination of premiums for supplement coverage and out-of-pocket expenses can put a huge strain on the finances of Medicare beneficiaries.”

EBRI

EBRI

For seniors enrolled in Medicare Advantage plans, the savings targets are typically lower, according to the report. A 65-year-old man enrolled in Medicare Advantage who has median drug expenditures and an average usage of health care services will need to save $96,000 to have a 9-in-10 chance of meeting medical bills in retirement. Meanwhile, a 65-year-old woman will need $113,000.

The EBRI report also factors in a provision of the Inflation Reduction Act that caps annual out-of-pocket Medicare Part D prescription drug outlays starting in 2025, so that no enrollee will pay more than $2,000 out of pocket per year.

That limit will affect 50 million Americans with Medicare Part D, and may guard enrollees from soaring costs. This provision will directly benefit the 1.4 million Medicare patients who spend more than $2,000 on medications each year, including people who need high-cost cancer drugs, according to an analysis from the Kaiser Family Foundation (KFF), a nonprofit organization.

‘Wildly conservative’

Importantly, this EBRI analysis does not weigh the potential costs of long-term-care expenses and other bills not covered by Medicare such as dental and vision care. These are often overlooked when planning for retirement.

The EBRI analysis does not weigh the potential costs of long-term-care expenses and other bills not covered by Medicare such as dental and vision care. (Getty Creative)

The EBRI analysis does not weigh the potential costs of long-term-care expenses and other bills not covered by Medicare such as dental and vision care. (Getty Creative)

“Planning the cost of health care is one of the hardest jobs,” Mary Johnson, policy analyst for The Senior Citizens League, told Yahoo Finance. “Not only do retirees need to save enough to replace about 70{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of pre-retirement earnings — just to live on — but we need to plan carefully for much larger sums once we get older and need more care in addition to just health care, such as to pay for aides to help with activities of daily living, cooking, cleaning or maintaining a home.”

“We are not wired to think this way,” Johnson said.

It also doesn’t take into account the fact that many people retire before becoming eligible for Medicare at 65 and typically shell out for their health insurance plan expenses out of their own pocket for a few retirement years. In EBRI’s 2022 Retirement Confidence Survey of 2,677 adults which included 1,132 retirees, over one in four (29{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) expected to retire at 70 or beyond or not at all, yet 62 was the median reported retirement age.

“These EBRI projections are wildly conservative,” Melinda Caughill, co-founder of the Medicare advice website 65 Incorporated, told Yahoo Finance. “This is unfortunately just the tip of the iceberg. We’re freaking out in this country because there’s the expectation for people that health care in retirement is free and should be free. But it’s not, and it’s not going to be. I wish there was a health care money tree, but there isn’t.”

‘Moving not for sunshine or palm trees’

These findings, conservative or not, should be a warning for Americans who still have years to retirement to consider contributing to a health savings account (HSA) To be eligible, though, you must be enrolled in a high-deductible health care plan.

For 2023, the annual inflation-adjusted limit on HSA contributions for self-only coverage under a high-deductible health plan will be $3,850, up from $3,650 in 2022. The HSA contribution limit for family coverage will be $7,750, up from $7,300.

Your HSA contribution with your employer can be made through an automatic payroll deduction where the funds are directed from your paycheck, tax-free, into an HSA. You can also add funds directly to your HSA at any time. While these contributions aren’t tax-free, they are deductible on your tax return. Some employers match contributions to HSAs similar to employer-provided retirement savings accounts. You can also open an account as a self-employed freelancer or business owner.

“From a tax perspective, a HSA is the best thing out there,” Fronstin previously told Yahoo Finance. “It benefits from a triple tax advantage. It’s the only account that lets somebody put money in on a tax-free basis, lets it build up tax-free, and lets it come out tax-free for qualified health care expenses.”

Another way to lower your future health care cost needs is by working longer. If workers receiving health benefits — and a paycheck — from their employer choose to work past age 65 and postpone enrollment in Medicare Parts B and D, they will need to have socked away less than EBRI researchers’ savings estimates, according to the report.

Happy mature executive assisting her younger coworker who is working on a computer in the office.
The number of those 65-and-older still on the job has been on the rise and is projected to increase further from a participation rate of 18.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in 2021 to 21.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in 2031, according to the (Getty Creative)

The number of those 65-and-older still on the job, however, has been on the rise and is projected to increase further from a participation rate of 18.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in 2021 to 21.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in 2031, according to the Bureau of Labor Statistics.

Finally, here’s another sizable cost-cutter for retirees eyeing relocating for their next chapter. Health care costs “vary incredibly based on where you live,” Caughill said.

In 2022, according to the Missouri Economic Research and Information Center’s Cost of Living Data series, health care costs in Maryland, for instance, were lower than in Florida or Arizona.

“What’s $100,000 in Arkansas can be $200,000 in Illinois or Wisconsin,” Caughill said. “Retirees should be moving not for sunshine or palm trees, but for health care costs.”

Kerry is a Senior Reporter and Columnist at Yahoo Finance. Follow her on Twitter @kerryhannon.

Click here for the latest economic news and economic indicators to help you in your investing decisions

Read the latest financial and business news from Yahoo Finance

Download the Yahoo Finance app for Apple or Android

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube.

Market Revenue Data for 2021, Estimates for 2022 and 2023, and CAGR Projections through 2027

Market Revenue Data for 2021, Estimates for 2022 and 2023, and CAGR Projections through 2027

DUBLIN, Feb. 6, 2023 /PRNewswire/ — The “Refurbished Medical Devices: Technologies and Global Markets” report has been added to  ResearchAndMarkets.com’s offering.

Research and Markets Logo

Research and Markets Logo

This report segments the global market by these geographic regions: North America, Europe, Asia and the Rest of the World. For market estimates, data is provided for 2020 as the base year, 2021, and forecast through year-end 2027.

Major factors driving the market include cost benefits provided by the refurbished devices, the growing elderly population in many countries, declining healthcare margins and expenditures, and environmental advantages. Challenges in the market include the lack of uniform regulations, and restrictions in the Indian and Chinese markets.

The COVID-19 pandemic’s impact on the global economy cannot be ignored. Lockdowns and the cessation of many non-essential medical treatments had a negative impact on the revenues of makes of refurbished medical devices. The industry is slowly rebounding from the impact, and the market for refurbished medical devices is expected to grow at a steady pace during the forecast period.

The circular economy is a major consideration by many of the top original equipment manufacturers (OEMs) such as Philips Healthcare and GE Healthcare, for their increased focus on refurbished devices. Environmentally conscious end users also prefer refurbished systems.

Major players, competitive intelligence, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for refurbished medical devices.

The scope of the report extends to only those medical device technologies that can be refurbished and generate the most revenues. Devices that cannot be refurbished and are recycled, and other small surgical instruments that are refurbished, are outside the scope of this report.

Report Includes

  • 56 data tables and 25 additional tables

  • A comprehensive overview and up-to-date analysis of the current and future global markets for refurbished medical devices/instruments

  • Analyses of the global market trends, with market revenue data for 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027

  • Market outlook and estimation of the actual market size for refurbished medical devices, revenue forecast, and corresponding market share analysis based on device type, application, and region

  • Highlights of the current state and future market potential of refurbished instruments, along with a detailed analysis of the competitive environment

  • Identification of the key growth driving factors and constraints that will shape the market for refurbished medical devices as the basis for projecting demand over the next five years (2022-2027)

  • Coverage of regulations and guidelines on refurbished devices followed in the U.S and Europe

  • Holistic review of the impact of COVID-19 on refurbished instruments, with pandemic implications on the demand and supply, pricing analysis, and various government strategic decisions to boost the marketplace

  • Analysis of the vendor landscape for refurbished medical devices market, and company value share analysis based on their segmental revenues

  • Company profiles of major players within the industry, including Canon Medical Systems Corp., GE Healthcare, Koninklijke Philips NV and Siemens Healthineers

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview
3.1 Introduction
3.2 Definition
3.3 Drivers, Restraints and Opportunities
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.3.4 Threats
3.3.5 Challenges
3.4 Regulations for Refurbished Medical Devices
3.4.1 Overview
3.4.2 Europe
3.4.3 U.S.
3.4.4 Japan

Chapter 4 Impact of Covid-19 Pandemic
4.1 Introduction
4.1.1 Supply Chain Disruption
4.1.2 Impact of Covid-19 in the U.S.

Chapter 5 Global Market for Medical Devices
5.1 Overview
5.2 Medical Imaging Equipment
5.2.1 Computed Tomography
5.2.2 Magnetic Resonance Imaging
5.2.3 X-Ray Machines
5.2.4 Ultrasound
5.2.5 Nuclear Medicine Systems (Pet, Spect and Pet/Ct)
5.2.6 Other Imaging Equipment
5.3 Operating Room Equipment
5.3.1 Anesthesia Machine
5.3.2 Electrosurgical Units
5.3.3 Operating Room Tables
5.3.4 Surgical Displays
5.3.5 Other Refurbished Operating Room Equipment
5.4 Patient Monitors
5.4.1 Multiparameter Monitors
5.4.2 Electrocardiography Devices
5.4.3 Pulse Oximeters
5.4.4 Mobile Cardiac Telemetry Devices
5.4.5 Other Patient Monitoring Devices
5.5 Cardiology Equipment
5.5.1 Defibrillators
5.5.1 Heart Lung Machines
5.6 Urology Instruments
5.6.1 Dialysis Machines
5.6.2 Lithotripsy Devices
5.7 Neurology Devices
5.7.1 Eeg Machines
5.7.2 Emg Machines
5.8 Icu Equipment
5.8.1 Ventilators
5.8.2 Infant Incubators and Warmers
5.9 Endoscopes
5.10 Dental Devices
5.11 Other Instruments
5.12 Global Market for Refurbished Medical Devices by End-user
5.12.1 Hospitals
5.12.2 Outpatient Facilities and Imaging Centers
5.12.3 Ambulatory Care Centers
5.12.4 Others

Chapter 6 Global Market for Medical Devices by Region
6.1 Introduction
6.2 North America
6.2.1 Canada
6.2.2 Inflation Reduction Act 2022
6.3 Europe
6.4 Asia
6.4.1 India
6.5 Rest of the World

Chapter 7 Competitive Landscape

Chapter 8 Company Profiles

  • Canon Medical Systems Corp.

  • Ge Healthcare

  • Koninklijke Philips Nv

  • Siemens Healthineers

  • Third Party Companies

  • Avante Health Solutions

  • Auxo Medical LLC

  • Block Imaging International Inc.

  • Everx Pvt. Ltd

  • Integrity Medical Systems Inc.

  • Hilditch Group Ltd.

  • Lbn Medical

  • Master Medical Equipment

  • Radiology Oncology Systems Inc.

  • Soma Technology International

For more information about this report visit https://www.researchandmarkets.com/r/w0llu9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

Cision

View original content:https://www.prnewswire.com/news-releases/global-refurbished-medical-devices-technologies-and-markets-report-2022-market-revenue-data-for-2021-estimates-for-2022-and-2023-and-cagr-projections-through-2027-301739456.html

SOURCE Research and Markets